The global pharmaceutical industry experienced a 25% decline in the number of future of work-related patent applications in Q2 2023 compared with the previous quarter. The total number of future of work-related grants dropped by 50% in Q2 2023, according to GlobalData’s Patent Analytics. GlobalData’s Future of Work – Thematic Research report explains how the theme future of work is impacting the workforce across different sectors, it presents key technology, macroeconomic and regulatory trends, market size and growth forecasts for technologies that will play a key role in the theme. Buy the report here.
Notably, the number of future of work-related patent applications in the pharmaceutical industry was 448 in Q2 2023, versus 599 in the prior quarter.
The top five companies accounted for 5% of patenting activity
Analysis of patenting activity by companies shows that Chinese Academy of Sciences filed the most future of work patents within the pharmaceutical industry in Q2 2023. The company filed 6 future of work-related patents in the quarter, compared with 3 in the previous quarter. It was followed by Sun Yat-sen University with 5 future of work patent filings, Ori Biotech (4 filings), and Danaher (4 filings) in Q2 2023.
Patenting activity was driven by China with a 44% share of total patent filings
The largest share of future of work related patent filings in the pharmaceutical industry in Q2 2023 was in China with 44%, followed by the US (28%) and Japan (5%). The share represented by China was 4% lower than the 48% share it accounted for in Q1 2023.
For further understanding of GlobalData's Future of Work – Thematic Research buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.